# Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye

> **NCT02815293** · PHASE3 · TERMINATED · sponsor: **Allergan** · enrollment: 36 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** AGN-195263
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT02815293
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09-30
- **Primary completion:** 2017-06-21
- **Final completion:** 2017-06-21
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02815293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02815293, "Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02815293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*